See more : Cargojet Inc. (CGJTF) Income Statement Analysis – Financial Results
Complete financial analysis of PAO Group, Inc. (PAOG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PAO Group, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Copperwired Public Company Limited (CPW.BK) Income Statement Analysis – Financial Results
- Bayer Aktiengesellschaft (BAYN.SG) Income Statement Analysis – Financial Results
- TRaaS On Product Inc. (6696.T) Income Statement Analysis – Financial Results
- Mapfre, S.A. (MPFRF) Income Statement Analysis – Financial Results
- EQ Inc. (CYPXF) Income Statement Analysis – Financial Results
PAO Group, Inc. (PAOG)
About PAO Group, Inc.
PAO Group, Inc. focuses on alternative patient care treatments. The company, through its subsidiaries, engages in the development, sale, and distribution of premium medical cannabis products for treatment of chronic and terminal patients. The company is headquartered in Sandusky, Ohio.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 287.82K |
| Cost of Revenue | 0.00 | 2.74K | 1.80K | 0.00 | 0.00 | 250.12K |
| Gross Profit | 0.00 | -2.74K | -1.80K | 0.00 | 0.00 | 37.70K |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 13.10% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 45.42K | 185.81K | 340.32K | 14.31K | 72.86K | 244.43K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | -4.13K | 0.00 |
| Operating Expenses | 45.42K | 185.81K | 340.32K | 14.31K | 76.99K | 244.43K |
| Cost & Expenses | 45.42K | 188.55K | 342.12K | 14.31K | 76.98K | 494.55K |
| Interest Income | 0.00 | 0.00 | 97.53K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 57.46K | 62.61K | 55.72K | 35.89K | 58.53K | 103.76K |
| Depreciation & Amortization | 167.90K | 228.49K | 236.56K | 206.30K | 171.86K | 161.14K |
| EBITDA | 292.96K | -188.55K | -244.59K | -14.31K | 1.20M | -206.73K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -71.83% |
| Operating Income | -45.42K | -188.55K | -342.12K | -14.31K | -76.99K | -206.73K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -71.83% |
| Total Other Income/Expenses | 280.93K | -62.61K | 41.81K | -37.24K | 1.22M | -103.76K |
| Income Before Tax | 235.51K | -251.16K | -300.30K | -51.55K | 1.14M | -310.49K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -107.88% |
| Income Tax Expense | -167.90K | -228.49K | -236.56K | -206.30K | -171.86K | -161.14K |
| Net Income | 235.51K | -251.16K | -300.30K | -51.55K | 1.14M | -310.49K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -107.88% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 1.91B | 1.91B | 1.91B | 1.40B | 914.18M | 815.18M |
| Weighted Avg Shares Out (Dil) | 1.91B | 1.91B | 1.91B | 1.40B | 914.18M | 815.18M |
PAOG Develops CBD Nutraceutical For $12.7 Billion Market From Patented Extract Process
PAOG Develops CBD Nutraceutical For $12.7 Billion Market From Patented Extract Process
PAOG Develops CBD Nutraceutical for $12.7 Billion from Patented Extract Process
Sandusky, Ohio--(Newsfile Corp. - December 18, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced the company expects to generate its first revenue next year in 2021 from its Cannabidiol (CBD) extraction technology, RespRx, acquired in July of this...
PAOG Announces Puerto Rico Consortium For Clinical Investigation Engagement To Advance CBD COPD Nutraceutical Care Solution
PAOG Announces Puerto Rico Consortium For Clinical Investigation Engagement To Advance CBD COPD Nutraceutical Care Solution
PURA with ALKM and PAOG Celebrate U.S. House Of Representatives Vote To End Marijuana Prohibition
PURA with ALKM and PAOG Celebrate U.S. House Of Representatives Vote To End Marijuana Prohibition
PURA with ALKM and PAOG Celebrate U.S. House Of Representatives Vote To End Marijuana Prohibition
Dallas, Texas--(Newsfile Corp. - December 4, 2020) - Puration, Inc. (OTC Pink: PURA) with partners Alkame Holdings (OTC Pink: ALKM) and PAO Group, Inc. (OTC Pink: PAOG) enthusiastically celebrate the U.S. House of Representatives today voting to pass (228-164) the...
PURA – Encourages Everyone To Email Congress Today In Support Of Marijuana Opportunity Reinvestment and Expungement Act
PURA – Encourages Everyone To Email Congress Today In Support Of Marijuana Opportunity Reinvestment and Expungement Act
PURA with PAOG and ALKM Partners Prepares For Anticipated Benefits From Marijuana Opportunity Reinvestment and Expungement Act
PURA with PAOG and ALKM Partners Prepares For Anticipated Benefits From Marijuana Opportunity Reinvestment and Expungement Act
PAOG CEO Discusses 2020 Progress And PURA Dividend On MoneyTV
PAOG CEO Discusses 2020 Progress And PURA Dividend On MoneyTV
PAOG CEO Discusses 2020 Progress And PURA Dividend On MoneyTV
Sandusky, Ohio--(Newsfile Corp. - November 25, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced an interview of CEO, Jim DiPrima on MoneyTV where Mr. DiPrima discusses the Company's progress in 2020 to include the latest updates on PAOG's...
PAOG Publishes First Financial Report Following Two Strategic Acquisitions
Dallas, Texas--(Newsfile Corp. - November 17, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced publishing its Q3 2020 report with OTC Markets. This is the first report since making two strategic acquisitions in the course of the third...
Source: https://incomestatements.info
Category: Stock Reports